BioSyent Dividends and Buybacks

Dividend criteria checks 1/6

BioSyent is a dividend paying company with a current yield of 1.61% that is well covered by earnings.

Key information

1.6%

Dividend yield

2.0%

Buyback Yield

Total Shareholder Yield3.6%
Future Dividend Yieldn/a
Dividend Growth-16.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCA$0.180
Payout ratio26%

Recent dividend and buyback updates

BioSyent's (CVE:RX) Dividend Will Be CA$0.045

Aug 30
BioSyent's (CVE:RX) Dividend Will Be CA$0.045

BioSyent (CVE:RX) Will Pay A Larger Dividend Than Last Year At CA$0.045

Feb 09
BioSyent (CVE:RX) Will Pay A Larger Dividend Than Last Year At CA$0.045

Recent updates

BioSyent's (CVE:RX) Dividend Will Be CA$0.045

Aug 30
BioSyent's (CVE:RX) Dividend Will Be CA$0.045

BioSyent's (CVE:RX) Profits May Not Reveal Underlying Issues

Mar 22
BioSyent's (CVE:RX) Profits May Not Reveal Underlying Issues

BioSyent (CVE:RX) Will Pay A Larger Dividend Than Last Year At CA$0.045

Feb 09
BioSyent (CVE:RX) Will Pay A Larger Dividend Than Last Year At CA$0.045

BioSyent Inc.'s (CVE:RX) Intrinsic Value Is Potentially 38% Above Its Share Price

Apr 14
BioSyent Inc.'s (CVE:RX) Intrinsic Value Is Potentially 38% Above Its Share Price

BioSyent Inc. (CVE:RX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Mar 19
BioSyent Inc. (CVE:RX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Declining Stock and Solid Fundamentals: Is The Market Wrong About BioSyent Inc. (CVE:RX)?

Mar 17
Declining Stock and Solid Fundamentals: Is The Market Wrong About BioSyent Inc. (CVE:RX)?

BioSyent (CVE:RX) Shareholders Booked A 33% Gain In The Last Year

Feb 18
BioSyent (CVE:RX) Shareholders Booked A 33% Gain In The Last Year

Here's Why BioSyent's (CVE:RX) Statutory Earnings Are Arguably Too Conservative

Jan 28
Here's Why BioSyent's (CVE:RX) Statutory Earnings Are Arguably Too Conservative

BioSyent Inc. (CVE:RX) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 07
BioSyent Inc. (CVE:RX) Shares Could Be 30% Below Their Intrinsic Value Estimate

BioSyent Inc.'s (CVE:RX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Dec 17
BioSyent Inc.'s (CVE:RX) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Did BioSyent Inc. (CVE:RX) Insiders Buy Up More Shares?

Dec 02
Did BioSyent Inc. (CVE:RX) Insiders Buy Up More Shares?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, RX has been paying a dividend for less than 10 years.

Growing Dividend: RX's dividend payments have increased, but the company has only paid a dividend for 2 years.


Dividend Yield vs Market

BioSyent Dividend Yield vs Market
How does RX dividend yield compare to the market?
SegmentDividend Yield
Company (RX)1.6%
Market Bottom 25% (CA)1.8%
Market Top 25% (CA)6.1%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (RX) (up to 3 years)n/a

Notable Dividend: RX's dividend (1.61%) isn’t notable compared to the bottom 25% of dividend payers in the Canadian market (1.78%).

High Dividend: RX's dividend (1.61%) is low compared to the top 25% of dividend payers in the Canadian market (6.13%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (26.3%), RX's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (107.5%), RX's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies